The Potentiating Effect of GLP-1 on Glucose-induced Glucagon Suppression in Healthy Individuals and in Patients with Type 1 and 2 Diabetes

被引:0
|
作者
Bagger, Jonatan I.
Lund, Asger
Grondahl, Magnus
Holst, Jens J.
Vilsboll, Tina
Knop, Filip K.
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1890-P
引用
收藏
页码:A487 / A487
页数:1
相关论文
共 50 条
  • [41] Determinant of the effectiveness of GLP-1 in type 2 diabetes
    Toft-Nielsen, MB
    Madsbad, S
    Damholt, MB
    Holst, JJ
    DIABETES, 2000, 49 : A127 - A127
  • [42] Efpeglenatide Glucagon-like peptide 1 (GLP-1) receptor agonist Treatment for type 2 diabetes
    Reid, J.
    Rana, K.
    Segel, S. A.
    Sheikh-Ali, M.
    Choksi, R. R.
    Goldfaden, R. F.
    DRUGS OF THE FUTURE, 2019, 44 (06) : 435 - 441
  • [43] Glucagon-like peptide 1 (GLP-1) as a new therapeutic approach for Type 2-diabetes
    Nauck, MA
    Holst, JJ
    Willms, B
    Schmiegel, W
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 1997, 105 (04) : 187 - 195
  • [44] GLP-1 based therapy for type 2 diabetes
    Arulmozhi, DK
    Portha, B
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2006, 28 (1-2) : 96 - 108
  • [45] Glucagon-like peptide-1 (GLP-1) in obese subjects with and without type 2 diabetes
    Rotella, CM
    Ognibene, A
    Cremasco, F
    Bardini, G
    Mencucci, A
    Pierazzuoli, E
    Ciani, S
    Messeri, G
    Mannucci, E
    DIABETES, 2000, 49 : A1 - A1
  • [46] Effect of a GLP-1 Receptor Agonist on Gastric Emptying, Parasympathetic Activity, and Insulin/Glucagon Secretion in Japanese Patients with Type 2 Diabetes
    Onishi, Tetsuro
    Mori, Yutaka
    Taniguchi, Yukiko
    Shioda, Yoshinobu
    DIABETES, 2014, 63 : A257 - A257
  • [47] Glucagon-like peptide 1 (GLP-1) in the treatment of diabetes
    Nauck, MA
    HORMONE AND METABOLIC RESEARCH, 2004, 36 (11-12) : 852 - 858
  • [48] THE EFFECT OF GLP-1 ON GLUCOSE ELIMINATION
    TOFTNIELSEN, M
    MADSBAD, S
    HOLST, JJ
    DIABETOLOGIA, 1995, 38 : A169 - A169
  • [49] Glycine-extended GLP-1 lowers glucose levels in type 2 diabetes
    不详
    DIABETES OBESITY & METABOLISM, 1999, 1 (02): : 121 - 121
  • [50] GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes
    Monney, Marine
    Jornayvaz, Francois R.
    Gariani, Karim
    DIABETES & METABOLISM, 2023, 49 (05)